Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tracy R Daniels-Wells

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Immunotherapy|July 5, 2016
Transferrin receptor 1: a target for antibody-mediated cancer therapyTracy R Daniels-Wells, Manuel L Penichet
Critical Reviews in Oncogenesis|July 25, 2013
Iron in multiple myelomaKristina VanderWall, Tracy R Daniels-Wells, Manuel Penichet, et al.
Current Topics in Microbiology and Immunology|January 3, 2015
IgE immunotherapy against cancerLai Sum Leoh, Tracy R Daniels-Wells, Manuel L Penichet
Cancers|September 28, 2023
A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple MyelomaPierre V Candelaria, Miguel Nava, Tracy R Daniels-Wells, et al.
Molecular Immunology|August 2, 2015
Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1Lai Sum Leoh, Tracy R Daniels-Wells, Otoniel Martínez-Maza, et al.
Molecular Immunology|November 14, 2016
Corrigendum to "Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1" [Mol. Immunol. 67 (2015) 407-415]Lai Sum Leoh, Tracy R Daniels-Wells, Otoniel Martínez-Maza, et al.
Frontiers in Immunology|April 5, 2021
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer AgentsPierre V Candelaria, Lai Sum Leoh, Manuel L Penichet, et al.
Frontiers in Immunology|January 31, 2018
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer TherapyJuan C Almagro, Tracy R Daniels-Wells, Sonia Mayra Perez-Tapia, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 25, 2022
Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief CommunicationPierre V Candelaria, Miguel Nava, Otoniel Martínez-Maza, et al.
Haematologica|December 12, 2024
hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse modelsTracy R Daniels-Wells, Pierre V Candelaria, Aileen M Rodriguez, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Immunotherapy|July 5, 2016
Transferrin receptor 1: a target for antibody-mediated cancer therapyTracy R Daniels-Wells, Manuel L Penichet
Critical Reviews in Oncogenesis|July 25, 2013
Iron in multiple myelomaKristina VanderWall, Tracy R Daniels-Wells, Manuel Penichet, et al.
Current Topics in Microbiology and Immunology|January 3, 2015
IgE immunotherapy against cancerLai Sum Leoh, Tracy R Daniels-Wells, Manuel L Penichet
Cancers|September 28, 2023
A Fully Human IgE Specific for CD38 as a Potential Therapy for Multiple MyelomaPierre V Candelaria, Miguel Nava, Tracy R Daniels-Wells, et al.
Molecular Immunology|August 2, 2015
Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1Lai Sum Leoh, Tracy R Daniels-Wells, Otoniel Martínez-Maza, et al.
Molecular Immunology|November 14, 2016
Corrigendum to "Insights into the effector functions of human IgG3 in the context of an antibody targeting transferrin receptor 1" [Mol. Immunol. 67 (2015) 407-415]Lai Sum Leoh, Tracy R Daniels-Wells, Otoniel Martínez-Maza, et al.
Frontiers in Immunology|April 5, 2021
Antibodies Targeting the Transferrin Receptor 1 (TfR1) as Direct Anti-cancer AgentsPierre V Candelaria, Lai Sum Leoh, Manuel L Penichet, et al.
Frontiers in Immunology|January 31, 2018
Progress and Challenges in the Design and Clinical Development of Antibodies for Cancer TherapyJuan C Almagro, Tracy R Daniels-Wells, Sonia Mayra Perez-Tapia, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 25, 2022
Combination Therapy of an Antibody Specific for Transferrin Receptor 1 (ch128.1/IgG1) With Bortezomib or Lenalidomide Results in Increased Survival in an In Vivo Model of Human Multiple Myeloma: A Brief CommunicationPierre V Candelaria, Miguel Nava, Otoniel Martínez-Maza, et al.
Haematologica|December 12, 2024
hu128.1, a humanized antibody targeting transferrin receptor 1, blocks erythroleukemia growth in xenograft mouse modelsTracy R Daniels-Wells, Pierre V Candelaria, Aileen M Rodriguez, et al.
Pageof 4